Progress in prenatal genetic diagnosis: Using cell-free fetal DNA in maternal blood

British Journal of Midwifery

Volumn 21, Issue 2, 2013, Pages 84-90

  Oxenford, Kerry ^a   Karunaratna, Madhavi ^a   Hill, Melissa ^b   Taffinder, Sally ^b   Chitty, Professor Lyn ^c  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874751049     PISSN: 09694900     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjom.2013.21.2.84     Document Type: Article

References (45)

1. Alberry M, Maddocks D, Jones M et al (2007) Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 27(5): 415-8
2. American College of Obstetricians and Gynecologists (2012) Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 120(6): 1532-4
3. Ashoor G, Syngelaki A, Wagner M et al (2012) Chromosomeselective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 206(4): 322 e1-5
4. Barrett AN, McDonnell TC, Chan KC et al (2012) Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia. Clin Chem 58(6): 1026-32
5. Benn P, Borrell A, Cuckle H et al (2012) Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011. Prenat Diagn 32(1): 1-2
6. Bianchi DW, Platt LD, Goldberg JD et al (2012) Genomewide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 119(5): 890-901
7. Chen EZ, Chiu RW, Sun H et al (2011) Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 6(7): e21791
8. Chitty LS, Finning K, Massey E et al (2011a) Antenatal determination of fetal Rhesus (RH) D status using cell free fetal DNA in the maternal circulation before 20 weeks gestation: is routine application practical and beneficial? Arch Dis Child Fetal Neonatal Ed 96(Suppl 1): Fa11-Fa12
9. Chitty LS, Griffin DR, Meaney C et al (2011b) New aids for the non-invasive prenatal diagnosis of achondroplasia: dysmorphic features, charts of fetal size and molecular confirmation using cell-free fetal DNA in maternal plasma. Ultrasound Obstet Gynecol 37(3): 283-9
10. Chitty LS, Hill M, White H et al (2012) Non-invasive prenatal testing for aneuploidy-ready for prime time? Am J Obstet Gynecol 206(4): 269-75
11. Chiu RW, Akolekar R, Zheng YW et al (2011) Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 342: c7401
12. Clausen FB, Christiansen M, Steffensen R et al (2011) Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion 52(4): 752-8
13. Clinical Molecular Genetics Society (2012) Clinical Molecular Genetics Society Audit of Data 2010-11 www.cmgs.org/ CMGS%20audit/2011%20audit/ CMGSAudit10-11-FINAL. pdf (accessed 17 January 2013)
14. Daniels G, Finning K, Martin P, Massey E (2009) Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenat Diagn 29(2): 101-7
15. de Jong A, Dondorp WJ, de Die-Smulders CE et al (2010) Non-invasive prenatal testing: ethical issues explored. Eur J Hum Genet 18(3): 272-7
16. Devaney SA, Palomaki GE, Scott JA,Bianchi DW (2011) Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis. JAMA 306(6): 627-36
17. Ehrich M, Deciu C, Zwiefelhofer T et al (2011) Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 204(3): 205 e1-11
18. Fan HC, Blumenfeld YJ, Chitkara U et al (2008) Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 105(42): 16266-71
19. Finning K, Martin P, Summers J et al (2008) Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 336(7648): 816-8
20. Finning KM, Chitty LS (2008) Non-invasive fetal sex determination: impact on clinical practice. Semin Fetal Neonatal Med 13(2): 69-75
21. Hill M, Finning K, Martin P et al (2011) Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet 80(1): 68-75
22. Hill M, Compton C, Lewis C et al (2012) Determination of foetal sex in pregnancies at risk of haemophilia: a qualitative study exploring the clinical practices and attitudes of health professionals in the United Kingdom. Haemophilia 18(4): 575-83
23. Hyett JA, Gardener G, Stojilkovic-Mikic T et al (2005) Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenat Diagn 25(12): 1111-6
24. Kelly SE, Farrimond HR (2012) Non-invasive prenatal genetic testing: A study of public attitudes. Public Health Genomics 15: 73-81
25. Lau TK, Chen F, Pan X et al (2011) Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing. J Matern Fetal Neonatal Med 25: 1370-4
26. Lewis C, Hill M, Skirton H, Chitty LS (2012a) Non-invasive prenatal diagnosis for fetal sex determination: benefits and disadvantages from the service users' perspective. Eur J Hum Genet 20(11): 1127-33
27. Lewis C, Hill M, Skirton H, Chitty LS (2012b) Fetal sex determination using cell-free fetal DNA: service users' experiences of and preferences for service delivery. Prenat Diagn 32(8): 735-41
28. Lo YM, Tein MS, Lau TK et al (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62(4): 768-75
29. Lo YM, Chiu RW (2007) Non-invasive prenatal diagnosis of Down's syndrome. Lancet 369(9578): 1997; author reply 1998-9
30. Newson AJ (2008) Ethical aspects arising from non-invasive fetal diagnosis. Semin Fetal Neonatal Med 13(2): 103-8
31. NHS Fetal Anomaly Screening Committee (2011) Screening for Down's syndrome: UK NSC Policy recommendations 2011-2014 Model of Best Practice. http://fetalanomaly.screening. nhs.uk/standardsandpolicies#fileid11393 (accessed 17 January 2013)
32. Nicolaides KH, Syngelaki A, Ashoor G et al (2012) Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 207(5): 374. e1-6
33. Oxenford K, Silcock C, Hill M, Chitty LS (2012) Routine testing of fetal Rhesus D status in Rhesus D negative women using cell free fetal DNA: an investigation into the preferences and information needs of women. RhD paper. Manuscript in preparation.
34. Palomaki GE, Kloza EM, Lambert-Messerlian GMH JE et al (2011) DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation. Genet Med 13(11): 913-20
35. Palomaki G, Deciu C, Kloza E et al (2012) DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med. 14: 296-305
36. Raymond FL, Whittaker J, Jenkins L et al (2010) Molecular prenatal diagnosis: the impact of modern technologies. Prenat Diagn 30(7): 674-81
37. Sayres LC, Allyse M, Norton ME et al (2011) Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation. Prenat Diagn 31(11): 1070-6
38. Scheffer PG, van der Schoot CE, Page-Christiaens GC, de Haas M (2011) Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience. BJOG 118(11): 1340-8
39. Schuster SC (2008) Next-generation sequencing transforms today's biology. Nat Methods 5(1): 16-8
40. Sehnert AJ, Rhees B, Comstock D et al (2011) Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 57(7): 1042-9
41. Sparks AB, Struble CA, Wang ET et al (2012) Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 206: 319.e1-9
42. Tischler R, Hudgins L, Blumenfeld YJ et al (2011) Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake. Prenat Diagn 31(13): 1292-9
43. van den Heuvel A, Chitty L, Dormandy E et al (2010) Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals. Patient Educ Couns 78(1): 24-8
44. Wright CF (2009) Cell-free fetal nucleic acids for non-invasive prenatal diagnosis. Report of the UK expert working group. PHG Foundation. www.phgfoundation.org/reports/4985 (accessed 17 January 2013)
45. UK Clinical Research Network (2012) RAPID Prenatal http://public.ukcrn. org.uk/search/StudyDetail. aspx?StudyID=8250 (accessed 17 January 2013)